Radar · Industry landscape · the United States
Healthtech Landscape of the United States 31,663 Healthtech companies in the United States, in one picture: who is hiring, who is raising money, who founded them, where they are based, what the news is about, which skills employers want and where the research is going. Updated August 2026.
31,663 companies tracked
$306.3B disclosed funding
2,207 hiring right now
13,043 events · 24 months
2,655,826 news articles · 12 months
Who leads Healthtech in the United States Shows 31,663 US healthtech firms and highlights the most active hiring companies, best‑funded firms, and those currently hiring, with 2,207 hiring and 7,695 having disclosed funding.
Radar
See all 31,663 Healthtech companies in the United States
Filter by funding, headcount, hiring and location, and export the list.
How the Healthtech ecosystem in the United States grew, 2016–2025 Displays the number of healthtech companies founded each year, peaking at 2,035 in 2020 and falling to 225 in 2025.
Companies founded / year
new Healthtech companies in the United States
2016: 1,612 2017: 1,603 2018: 1,648 2019: 1,658 2020: 2,035 2021: 1,471 2022: 1,094 2023: 925 2024: 674 2025: 225 2016 2025
peak 2,035 in 2020
Companies raising / year
with a disclosed round that year
2016 2025
peak 1,489 in 2021
Disclosed funding / year
sum of disclosed rounds (USD)
2016: 13,935,027,413 2017: 15,361,734,030 2018: 22,564,096,888 2019: 26,296,462,571 2020: 28,879,645,532 2021: 31,776,443,458 2022: 23,064,945,105 2023: 16,157,602,522 2024: 14,640,418,226 2025: 22,291,811,683 2016 2025
peak $31.8B in 2021
Where Healthtech companies in the United States are based Lists the cities with the highest counts of healthtech firms, led by New York City (1,512) and San Francisco (1,294).
→ Hub 01
New York City
1,512 Healthtech companies
26% of the Healthtech companies across these hubs
1,512 companies
$18.9B disclosed funding
131 hiring now
Hub 02
San Francisco
1,294 Healthtech companies
22% of the Healthtech companies across these hubs
1,294 companies
$25.9B disclosed funding
124 hiring now
Hub 03
Los Angeles
602 Healthtech companies
10% of the Healthtech companies across these hubs
602 companies
$3.8B disclosed funding
42 hiring now
Hub 04
Boston
576 Healthtech companies
10% of the Healthtech companies across these hubs
576 companies
$11.8B disclosed funding
56 hiring now
Hub 05
San Diego
541 Healthtech companies
9% of the Healthtech companies across these hubs
541 companies
$12.3B disclosed funding
42 hiring now
Hub 06
Austin
485 Healthtech companies
8% of the Healthtech companies across these hubs
485 companies
$3.9B disclosed funding
36 hiring now
Hub 07
Chicago
461 Healthtech companies
8% of the Healthtech companies across these hubs
461 companies
$3.7B disclosed funding
53 hiring now
Hub 08
Atlanta
348 Healthtech companies
6% of the Healthtech companies across these hubs
348 companies
$1.8B disclosed funding
26 hiring now
The Healthtech market map of the United States: what these companies actually do Breaks down product sub‑categories, showing enterprise tech as the largest (15,915 firms), and notes subscription as the most common revenue model (17,239 firms).
Enterprise Tech 15,915 companies · $230.7B raised · 1,451 hiring Consumer Digital 8,667 companies · $58.9B raised · 563 hiring Enterprise Software 7,907 companies · $73.6B raised · 692 hiring Life Sciences 7,143 companies · $154.3B raised · 613 hiring SaaS 4,397 companies · $52.6B raised · 429 hiring Healthtech SaaS 4,010 companies · $43.5B raised · 382 hiring B2C E-Commerce 1,942 companies · $7.4B raised · 86 hiring IoT in Healthcare 1,445 companies · $18.6B raised · 93 hiring Hospital at Home 1,403 companies · $11.4B raised · 101 hiring Deep Tech 1,272 companies · $36.2B raised · 106 hiring Loneliness Economy 1,266 companies · $10.9B raised · 93 hiring At Home Diagnostics 1,195 companies · $14.4B raised · 74 hiring Monetization
How Healthtech companies make money How many companies earn revenue each way. Plenty use more than one model, so the counts add up to more than the sector.
Subscription 17,239
E-Commerce - Product 8,103
Physical Commerce 7,200
Fee-For-Service 3,809
Commission on Transaction 2,259
E-Commerce - Service 1,750
Advertising 1,327
Sponsorship 83
Funding, M&A and the deals moving Healthtech in the United States Counts 13,043 corporate events over the past two years, including earnings releases (3,558), key‑person announcements (2,453), and funding rounds (1,911).
Earnings 3,558 Leadership 2,453 Funding 1,911 M&A 1,787 Announcement 620 Lawsuit 471 Contracts 441 IPO 393 Assets 386 Product 220
Funding Aclarion Inc. (Nasdaq: ACON), a Broomfield-based health-care technology that early this year raised $10.4 million through a stock sale, recently reported that its “existing cash resources are sufficient to fund operations into the second half of 2027.” 2026-05-05 M&A Candid is choosing the M&A route instead, opting to accept a $2 billion buyout offer that gives UCB the biotech’s pipeline of T cell engagers for immune disorders. 2026-05-05 Funding With these funds, combined with net proceeds from a recent $80 million public offering, the company reports cash and cash equivalents balance of approximately $64.6 million as of March 31, 2026. 2026-05-04 M&A Global investment firm Carlyle (NASDAQ: CG) today announced it has acquired a majority stake in Knack RCM (“Knack”) and EqualizeRCM (“Equalize”), two leading U.S. healthcare revenue cycle management (“RCM”) providers, to create an AI-native, global, multi-specialty RCM platform. 2026-05-04 Funding Techcyte has now raised a total of $50.4M in total equity funding and is backed by Mayo Clinic, Van Tuyl Companies, and Zoetis. 2026-05-04 M&A SnapCare acquires connectRN 2026-05-04 M&A Medisolv acquires Health Elements Medisolv has acquired Health Elements, a developer of healthcare data abstraction software. 2026-05-04 M&A Securitas Healthcare, part of Securitas Technology, has acquired ZulaFly. 2026-05-04 M&A Hussman Strategic Advisors Inc. acquired a new stake in TransMedics Group, Inc. (NASDAQ:TMDX – Free Report) during the fourth quarter, according to its most recent 13F filing with the SEC. 2026-05-03 Funding Iterative Health has netted $77m in a Series C funding round to expand and scale its artificial intelligence (AI)-powered clinical research network, which the company claims can address ongoing recruitment challenges faced by trial sponsors. 2026-05-01 Mergers and acquisitions Deals from the last 24 months where a Healthtech company in the United States was the buyer or the one bought, newest first. “Undisclosed” means the price was never published — not that the deal was worth nothing.
Acquirer Target Deal value Status Date novartisAlcon undisclosed Announced 2026-06-25 Boston Scientific Enteric Medical Technologies undisclosed Completed 2026-05-30 regeneron pharmaceuticals23andMe $256M Announced 2026-05-19 omnicomIPG undisclosed Completed 2026-05-05 reliance retailAnomaly undisclosed Completed 2026-05-05 UCB S.A. Candid $2B Announced 2026-05-05
Who is listing, hiring leaders, launching and winning work Provides details on specific events such as IPO filings, leadership changes, product launches, and contract wins.
IPO pipeline
66 companies listed or filing · last 24 months
Contract wins
244 customer wins · last 24 months
Workforce actions
50 companies cutting roles · last 24 months
Earnings pulse
companies reporting results · last 24 months
374 companies reporting3,845 company-quarters trackedbeat 979 miss 264 in line 105
Half of these companies grew revenue faster than +11.0% , half slower.
Who is building Healthtech in the United States Profiles 15,537 founders and CEOs across 11,555 firms, noting top alma maters like Stanford (391) and common prior employers such as Google (85).
Founders and chief executives 12 of 15,537, from the best-funded companies on this page
→ Chairman President & CEO
Stephen M
Ex- Stryker, Pharmacia, Procter & Gamble, Johnson & Johnson, Boston Scientific. Davidson College BA 1985
Chairman & CEO
Stephen GillettG
Granular Insurance, Google, ex-Co-Founder Chronicle, Symantec, Best Buy, Yahoo. University of Oregon BS 1998, San Francisco State University MBA 2006
Chief Executive Officer & President
Pete Arduini
Ex-Baxter Healthcare, GE Healthcare, Procter and Gamble. Susquehanna University, Northwestern University's Kellogg School of Management
Ex-Co-Founder Medisense. Imperial College London 1975, Harvard Business School MBA 1981
Chief Executive Officer
Bob Ragusa
Dante Labs, ex-Affymetrix, ex-Life Technologies, University of Connecticut
CEO & President
Kevin Sayer
Ex-CFO Biosensors International. Brigham Young University BS 1983
Chairman and Co-Chief Executive Officer
Helmy Eltoukhy
repeat founder Sheffield United Football Club, ex-Illumina. Stanford University BS 2000, MS 2001, PhD 2006
Chairman & CEO
Kevin Conroy
Exact Sciences, ex-Third Wave Technologies, ex-Ge Healthcare, University of Michigan Law School, 1991
Ex-CEO Covidien, Tyco Healthcare, Accenture. University Center of the Maua Institute of Technology
CEO & President & Founder
Deepak Chopra
ex-Intel Corporation, TRW Semiconductors, RCA Semiconductors. Punjab Engineering College in Chandigarh BSc, University of Massachusetts, Amherst MSc.
Co-Founder & CPO
Riley Ennis
Foundation, Co-Founder Freenome & Oncolinx, ex-Foundation Medicine, Syros Pharmaceuticals, Morgan Stanley. Dartmouth College BA 2015
Co-Founder, President
Dongjin Seo
Caltech BS, University of California, Berkeley PhD
Where the founders studied
alma mater on record for 2,665 of 15,537 founders
Stanford University 391
Harvard University 355
Massachusetts Institute of Technology 280
University of Pennsylvania 218
Harvard Business School 209
Cornell University 167
University of California (Berkeley) 140
Duke University 139
Where they worked before
a previous employer on record for 390 of 15,537 founders
Google 85
McKinsey 56
Microsoft 54
Amazon 35
Facebook 30
Goldman Sachs 28
Intel 26
Morgan Stanley 23
Founders flagged as repeat founders
of 12,874 founders with a profile on this page
153
carry a repeat-founder flag
flagged as repeat founders 153 no repeat-founder flag 12,721 Women and men among the founders
first names matched for 14,191 of 15,537 founders
17%
of matched founders are women
Inferred from first names, using 119 million people who state their own gender: a first name counts only where at least 20 of them share it and at least 90% of those share the same gender. The other 1,346 founders go in neither column.
Radar
Look up the people behind Healthtech companies in the United States
Search founders, executives and operators by company, role and location.
Who funds Healthtech in the United States Summarizes 18,120 funding rounds since 2016 from 7,375 investors, with a typical round size of $2.2 million.
Stage mix · rounds since 2016
Seed & Angel 5,212
Series A–B 5,375
Series C+ / PE 1,726
Grants, debt & other 5,807
The typical round is $2.2M — half were bigger, half smaller.
The biggest Healthtech funding rounds in the United States Highlights the largest disclosed round—a $1.5 billion Series D for MiRus—and lists ten other large recent rounds.
Company Round Size When Backers MiRus Series Dmega-round $1.5B May 2026 Boston Scientific GRAIL Series Bmega-round $1.2B Feb 2017 Arch Venture Partners , Johnson & Johnson Innovation , McKesson Ventures +5 more VillageMD Series Cmega-round $1B Jun 2020 Walgreens Boots Alliance , Kinnevik Caris Life Sciences Series Dmega-round $830M May 2021 T. Rowe Price , Silver Lake , Fidelity Investments +8 more Title21 Health Solutions Series Dmega-round $656.3M Jul 2022 ARCHIMED Neuralink Series Emega-round $650M May 2025 Founders Fund , Google Ventures , Sequoia Capital +3 more Smile Doctors Series Dmega-round $550M Jul 2023 — Intarcia Series Jmega-round $524.6M Aug 2017 Gates Commure Series Dmega-round $509.2M Sep 2021 Greenoaks , Human Capital Outcome Health Series Cmega-round $500M May 2017 CapitalG , Pritzker Group , Balyasny Asset Management +3 more
Venture round sizes · 2023–2025
<$1M 615
$1–10M 1,187
$10–50M 685
$50–250M 194
>$250M 14
2,695 venture rounds with a disclosed amount in the window.
Fresh cheques · last 6 months
What the news says about Healthtech in the United States Counts 2,655,826 news articles in the last year, with coverage focused on administrative, geopolitical, and international political topics.
News volume
Healthtech coverage across United States · articles per quarter
2021Q2: 567,955 2021Q3: 589,515 2021Q4: 551,601 2022Q1: 593,461 2022Q2: 571,072 2022Q3: 580,046 2022Q4: 637,883 2023Q1: 668,998 2023Q2: 670,838 2023Q3: 601,522 2023Q4: 572,133 2024Q1: 605,853 2024Q2: 582,242 2024Q3: 565,958 2024Q4: 593,752 2025Q1: 907,773 2025Q2: 603,982 2025Q3: 1,363,064 2025Q4: 328,315 2026Q1: 442,231 2021Q2 2026Q1
peak 1,363,064 in 2025Q3 · 2,655,826 articles in the last 12 tracked months
Tone of coverage
share of articles by dominant sentiment (positive / neutral / negative )
2021 2023 2025
Positive-tone share moved 26% → 26%, negative 23% → 29% across 2021–2025.
What the coverage is about The subjects that dominate Healthtech news in United States. The arrow shows whether each one is being written about more or less than a year ago.
Administrative and political subdivisions 4,359,394 ▲+20% Geopolitical disputes and contested areas 320,877 ▲+34% International and transnational geographic entities 320,716 ▲+34% International political relations 199,241 ▲+35% Security and defense policies 140,368 ▲+61% International relations and diplomacy 90,847 ▲+22% Geographic naming conventions and etymology 82,170 ▲+453% Trade policies and agreements 74,825 →+9% Covid-19 vaccine development and efficacy trials 74,240 ▲+293% Human rights advocacy reports 70,592 →+4% Most-covered companies · last 12 months
Abbott 11,380 IBM Watson Health 7,738 Phil 6,245 Alma 3,912 Vecna 3,026 Medtronic 3,025 Baxter 2,120 MRO 1,900 GE Healthcare 1,836 Renee 1,748 1,000 Healthtech companies here were named in the news over this period.
Prism
Watch Healthtech coverage in United States as it happens
Prism follows these subjects story by story — which companies are named, what is said about them and how the tone moves.
Momentum
The words getting louder — and quieter Which terms are showing up in more stories than a year ago, and which are fading. The percentage is the change in how many articles mention them.
foreign policy analysis+50% multilateral diplomacy+62% national security strategy+127% bilateral trade+40% diplomatic engagements+58% vaccine candidates+288% vaccine trials+259% vaccination campaigns+381% countries+122% vaccine immunogenicity+276%
olympic team selections-50% olympic trials-53% ceasefire violations-47% summer olympics athletics-87% electioneering tactics-57%
The pressures the press keeps returning to Three recurring angles in United States Healthtech coverage, and whether each is getting more attention year on year (through 2025).
Regulatory Risk ▲ rising
1,911,493 articles touch this dimension · 42.5% critical tone
2021 2025
signals: territories, disputed islands, vaccine mandate compliance
Funding Momentum ▲ rising
376,845 articles touch this dimension · 46.9% critical tone
2021 2025
signals: public health funding, investment deal, inflation reports fx
Growth ▲ rising
535,611 articles touch this dimension · 35.3% critical tone
2021 2025
signals: earnings report, quarterly results, quarterly financials
Healthtech jobs in the United States: who is hiring and what they ask for Reports 119,010 job postings from 2,741 employers in 12 months, emphasizing skills like Excel and Python and a median advertised salary of $80 k per year.
119,010 postings · last 12 months
178,741 postings tracked overall
2,741 employers advertising
$80k median advertised salary/yr (n=16791)
Demand
The Skills Employers Ask For What Healthtech employers in the United States put in their job ads. The bar is how many postings ask for it; the arrow shows whether demand grew or shrank against the year before.
excel 1,974 ▲ python 1,009 ▲ sql 1,005 ▲ powerpoint 959 ▲ word 958 ▲ microsoft office 865 ▲ salesforce 747 ▲ aws 684 ▲ typescript 618 ▲ outlook 597 ▲ What level are these roles?
Entry 2,060
Intern 2,122
Senior 12,572
Lead 4,937
Manager 25,713
What they pay, by level
Manager $105k/yr (n=2612) Senior $107k/yr (n=1821) Lead $119k/yr (n=980) Intern $46k/yr (n=122) Entry $44k/yr (n=341) Most advertised titles
Assistant Manager 1,502 Licensed Clinical Social Worker 1,421 Family Medicine Physician 1,200 Insurance Agent 1,181 Medical Assistant 1,129 Licensed Clinical Psychologist 937 12 Healthtech-relevant internships in India were advertised over the same 12 months.
What Healthtech research in the United States is working on Shows 8,843 academic papers from India‑affiliated institutions, with 2,938 identifying common problems and 3,687 outlining opportunities.
How this field talks about itself
United States-affiliated Healthtech papers (gold) against all published research (grey)
Problem-identifying 32.5% · 9.7% 3.4×
Promising 29.8% · 37.7% 0.8×
Descriptive 14.9% · 17.2% 0.9×
Breakthrough 11.9% · 26.3% 0.5×
Cautionary 7.3% · 4.3% 1.7×
Comparative 2.9% · 3.8% 0.8×
United States-affiliated Healthtech literature runs 3.4× more “problem-identifying” than science at large (32.5% vs 9.7% baseline).
How the work is done
Empirical 41.3%
Methods-led 23.4%
Position pieces 17.5%
Reviews 17.2%
Theoretical 0.6%
How the research reads
87% positive · 4% neutral · 9% negative , across 8,843 papers.
The institutions doing the work · United States
VA Center for Clinical Management Research 24k VA Ann Arbor Healthcare System 22k Harvard University 22k University of Michigan–Ann Arbor 18k Louis Stokes Cleveland VA Medical Center 15k University of North Carolina at Chapel Hill 10k ranked by how often their work is cited
Leading researchers · United States-affiliated work
Laura J. Damschroder · David C. Aron · Susan Kirsh · Rosalind E. Keith · J Alexander · Byron J. Powell · Thomas J. Waltz · Matthew Chinman
The most-cited breakthroughs
Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science · 14k cites Mapping ICD-10 and ICD-10-CM Codes to Phecodes: Workflow Development and Initial Evaluation · 547 cites PRISM framework: a paradigm shift for designing, strengthening and evaluating routine health information systems · 510 cites Dipole · 485 cites Polymer Genome: A Data-Powered Polymer Informatics Platform for Property Predictions · 471 cites Common problems researchers identify 10,590 papers · 7 recurring themes
→ Problems · theme 01
Challenges in Drug Discovery
1,081 papers · 18.0% of this block
2022: 156 of every 10,000 papers on this subject 2023: 161 of every 10,000 papers on this subject 2024: 168 of every 10,000 papers on this subject 2025: 210 of every 10,000 papers on this subject 2022: 156 of every 10,000 papers on this subject 2023: 161 of every 10,000 papers on this subject 2024: 168 of every 10,000 papers on this subject 2025: 210 of every 10,000 papers on this subject ▲ +35% share 2022→2025 share of research on this subject Researchers highlight difficulties in identifying effective compounds and translating findings into viable therapies.
Drug discovery · Drug · Pharmacogenomics · Drug development
“Cancer epigenetics drug discovery and development: the challenge of hitting the mark”
Problems · theme 02
Barriers to Telehealth Adoption
1,079 papers · 18.0% of this block
2022: 541 of every 10,000 papers on this subject 2023: 554 of every 10,000 papers on this subject 2024: 539 of every 10,000 papers on this subject 2025: 840 of every 10,000 papers on this subject 2022: 541 of every 10,000 papers on this subject 2023: 554 of every 10,000 papers on this subject 2024: 539 of every 10,000 papers on this subject 2025: 840 of every 10,000 papers on this subject ▲ +55% share 2022→2025 share of research on this subject Studies point to accessibility, equity, and evaluation gaps that limit telemedicine’s reach.
Telemedicine · Telehealth · Health care · Nursing
“Ensuring full participation of people with disabilities in an era of telehealth”
Problems · theme 03
Health System Integration Issues
815 papers · 13.6% of this block
2022: 22 of every 10,000 papers on this subject 2023: 20 of every 10,000 papers on this subject 2024: 27 of every 10,000 papers on this subject 2025: 44 of every 10,000 papers on this subject 2022: 22 of every 10,000 papers on this subject 2023: 20 of every 10,000 papers on this subject 2024: 27 of every 10,000 papers on this subject 2025: 44 of every 10,000 papers on this subject ▲ +98% share 2022→2025 share of research on this subject Work examines fragmented administration, nursing, and informatics practices that hinder coordinated care.
Health administration · Nursing research · Health informatics · Public health
“Is Europe putting theory into practice? A qualitative study of the level of self-management support in chronic care management approaches”
Problems · theme 04
Limits of Precision Medicine
815 papers · 13.6% of this block
2022: 764 of every 10,000 papers on this subject 2023: 1,050 of every 10,000 papers on this subject 2024: 799 of every 10,000 papers on this subject 2025: 777 of every 10,000 papers on this subject 2022: 764 of every 10,000 papers on this subject 2023: 1,050 of every 10,000 papers on this subject 2024: 799 of every 10,000 papers on this subject 2025: 777 of every 10,000 papers on this subject → +2% share 2022→2025 share of research on this subject Authors discuss obstacles in tailoring treatments to individual disease subtypes and patient genetics.
Precision medicine · Personalized medicine · Cancer · Disease
“The growing role of precision and personalized medicine for cancer treatment”
Problems · theme 05
Digital Health Implementation Gaps
810 papers · 13.5% of this block
2022: 540 of every 10,000 papers on this subject 2023: 553 of every 10,000 papers on this subject 2024: 541 of every 10,000 papers on this subject 2025: 849 of every 10,000 papers on this subject 2022: 540 of every 10,000 papers on this subject 2023: 553 of every 10,000 papers on this subject 2024: 541 of every 10,000 papers on this subject 2025: 849 of every 10,000 papers on this subject ▲ +57% share 2022→2025 share of research on this subject Papers note mismatches between digital tools and universal health coverage goals.
Digital health · Health care · Health informatics · Informatics
“Technology and Universal Health Coverage: Examining the role of digital health”
Problems · theme 06
Pandemic‑Driven Telemedicine Strains
783 papers · 13.1% of this block
2022: 661 of every 10,000 papers on this subject 2023: 444 of every 10,000 papers on this subject 2024: 330 of every 10,000 papers on this subject 2025: 213 of every 10,000 papers on this subject 2022: 661 of every 10,000 papers on this subject 2023: 444 of every 10,000 papers on this subject 2024: 330 of every 10,000 papers on this subject 2025: 213 of every 10,000 papers on this subject ▼ -68% share 2022→2025 share of research on this subject Research flags unequal access and rapid scaling challenges during COVID‑19.
Pandemic · Coronavirus disease 2019 · 2019-20 coronavirus outbreak · Telemedicine
“Telemedicine and health access inequalities during the COVID-19 pandemic”
Problems · theme 07
Medical Device Safety Concerns
617 papers · 10.3% of this block
2022: 564 of every 10,000 papers on this subject 2023: 578 of every 10,000 papers on this subject 2024: 564 of every 10,000 papers on this subject 2025: 876 of every 10,000 papers on this subject 2022: 564 of every 10,000 papers on this subject 2023: 578 of every 10,000 papers on this subject 2024: 564 of every 10,000 papers on this subject 2025: 876 of every 10,000 papers on this subject ▲ +55% share 2022→2025 share of research on this subject Studies raise issues around standards, usability, and interoperability of wearable and implantable devices.
Medical device · Wearable computer · Health care · Food and drug administration
“The Need to Apply Medical Device Informatics in Developing Standards for Safe Interoperable Medical Systems”
Cautions 2,527 papers · 7 recurring themes
→ Cautions · theme 01
Caution on Remote Chronic Care
619 papers · 24.5% of this block
2022: 215 of every 10,000 papers on this subject 2023: 197 of every 10,000 papers on this subject 2024: 210 of every 10,000 papers on this subject 2025: 199 of every 10,000 papers on this subject 2022: 215 of every 10,000 papers on this subject 2023: 197 of every 10,000 papers on this subject 2024: 210 of every 10,000 papers on this subject 2025: 199 of every 10,000 papers on this subject ▼ -8% share 2022→2025 share of research on this subject Evidence urges careful assessment of telehealth’s effectiveness and cost‑benefit for long‑term disease management.
Telemedicine · Telehealth · Medical emergency · Health care
“Home telehealth for chronic disease management: A systematic review and an analysis of economic evaluations”
Cautions · theme 02
Governance and Informatics Risks
400 papers · 15.8% of this block
2022: 22 of every 10,000 papers on this subject 2023: 20 of every 10,000 papers on this subject 2024: 27 of every 10,000 papers on this subject 2025: 44 of every 10,000 papers on this subject 2022: 22 of every 10,000 papers on this subject 2023: 20 of every 10,000 papers on this subject 2024: 27 of every 10,000 papers on this subject 2025: 44 of every 10,000 papers on this subject ▲ +98% share 2022→2025 share of research on this subject Authors caution about data governance, system integration, and staffing challenges in health informatics.
Health informatics · Health administration · Nursing research · Health care
“A systematic approach to the planning, implementation, monitoring, and evaluation of integrated health services”
Cautions · theme 03
COVID‑19 Telehealth Perception Issues
389 papers · 15.4% of this block
2022: 548 of every 10,000 papers on this subject 2023: 379 of every 10,000 papers on this subject 2024: 244 of every 10,000 papers on this subject 2025: 190 of every 10,000 papers on this subject 2022: 548 of every 10,000 papers on this subject 2023: 379 of every 10,000 papers on this subject 2024: 244 of every 10,000 papers on this subject 2025: 190 of every 10,000 papers on this subject ▼ -65% share 2022→2025 share of research on this subject Surveys reveal patient and clinician concerns about quality and trust in pandemic‑era virtual care.
Pandemic · Coronavirus disease 2019 · Telemedicine · Telehealth
“Patient Perception of Telehealth Services for Breast and Gynecologic Oncology Care during the COVID-19 Pandemic: A Single Center Survey-base”
Cautions · theme 04
Pharmacogenomics Validation Limits
365 papers · 14.4% of this block
2022: 156 of every 10,000 papers on this subject 2023: 161 of every 10,000 papers on this subject 2024: 168 of every 10,000 papers on this subject 2025: 210 of every 10,000 papers on this subject 2022: 156 of every 10,000 papers on this subject 2023: 161 of every 10,000 papers on this subject 2024: 168 of every 10,000 papers on this subject 2025: 210 of every 10,000 papers on this subject ▲ +35% share 2022→2025 share of research on this subject Research highlights insufficient evidence and population diversity for routine pharmacogenomic testing.
Pharmacogenomics · Drug discovery · Drug · Pharmacology
“Pharmacogenomic Testing and Depressive Symptom Remission: A Systematic Review and <scp>Meta‐Analysis</scp> of Prospective, Controlled Clinic”
Cautions · theme 05
Digital Mental‑Health Intervention Limits
289 papers · 11.4% of this block
2022: 785 of every 10,000 papers on this subject 2023: 800 of every 10,000 papers on this subject 2024: 802 of every 10,000 papers on this subject 2025: 1,143 of every 10,000 papers on this subject 2022: 785 of every 10,000 papers on this subject 2023: 800 of every 10,000 papers on this subject 2024: 802 of every 10,000 papers on this subject 2025: 1,143 of every 10,000 papers on this subject ▲ +46% share 2022→2025 share of research on this subject Analyses point to mixed efficacy and ethical concerns in automated mental‑health solutions.
Psychological intervention · Digital health · Mental health · Intervention
“Digital Health Interventions to Enhance Prevention in Primary Care: Scoping Review”
Cautions · theme 06
Precision Oncology Practical Hurdles
285 papers · 11.3% of this block
2022: 764 of every 10,000 papers on this subject 2023: 1,050 of every 10,000 papers on this subject 2024: 799 of every 10,000 papers on this subject 2025: 777 of every 10,000 papers on this subject 2022: 764 of every 10,000 papers on this subject 2023: 1,050 of every 10,000 papers on this subject 2024: 799 of every 10,000 papers on this subject 2025: 777 of every 10,000 papers on this subject → +2% share 2022→2025 share of research on this subject Papers discuss limited clinical impact and biomarker validation challenges in cancer precision therapies.
Precision medicine · Personalized medicine · Cancer · Oncology
“Impact of Precision Medicine in Diverse Cancers: A Meta-Analysis of Phase II Clinical Trials”
Cautions · theme 07
AI Integration Uncertainties
180 papers · 7.1% of this block
2022: 544 of every 10,000 papers on this subject 2023: 558 of every 10,000 papers on this subject 2024: 546 of every 10,000 papers on this subject 2025: 875 of every 10,000 papers on this subject 2022: 544 of every 10,000 papers on this subject 2023: 558 of every 10,000 papers on this subject 2024: 546 of every 10,000 papers on this subject 2025: 875 of every 10,000 papers on this subject ▲ +61% share 2022→2025 share of research on this subject Authors warn of data bias, interpretability, and regulatory gaps when applying AI to personalized care.
Applications of artificial intelligence · Health care · Precision medicine · Personalized medicine
“Leveraging Artificial Intelligence for Predictive Healthcare: A Data-Driven Approach to Early Diagnosis and Personalized Treatment”
Opportunities 19,256 papers · 7 recurring themes
→ Opportunities · theme 01
Expanding Telehealth for Seniors
1,108 papers · 18.5% of this block
2022: 549 of every 10,000 papers on this subject 2023: 380 of every 10,000 papers on this subject 2024: 246 of every 10,000 papers on this subject 2025: 195 of every 10,000 papers on this subject 2022: 549 of every 10,000 papers on this subject 2023: 380 of every 10,000 papers on this subject 2024: 246 of every 10,000 papers on this subject 2025: 195 of every 10,000 papers on this subject ▼ -64% share 2022→2025 share of research on this subject Studies explore how virtual care can improve access and outcomes for older adults.
Telehealth · Telemedicine · Pandemic · Coronavirus disease 2019
“Urgent and non-emergent telehealth care for seniors: Findings from a multi-site impact study”
Opportunities · theme 02
Computational Drug Design Advances
973 papers · 16.2% of this block
2022: 182 of every 10,000 papers on this subject 2023: 196 of every 10,000 papers on this subject 2024: 225 of every 10,000 papers on this subject 2025: 259 of every 10,000 papers on this subject 2022: 182 of every 10,000 papers on this subject 2023: 196 of every 10,000 papers on this subject 2024: 225 of every 10,000 papers on this subject 2025: 259 of every 10,000 papers on this subject ▲ +42% share 2022→2025 share of research on this subject Research showcases in‑silico methods accelerating target identification and molecule optimization.
Drug discovery · Computational biology · Chemical space · Drug
“Assessing molecular docking tools: understanding drug discovery and design”
Opportunities · theme 03
Integrated Digital Health Platforms
948 papers · 15.8% of this block
2022: 540 of every 10,000 papers on this subject 2023: 553 of every 10,000 papers on this subject 2024: 541 of every 10,000 papers on this subject 2025: 849 of every 10,000 papers on this subject 2022: 540 of every 10,000 papers on this subject 2023: 553 of every 10,000 papers on this subject 2024: 541 of every 10,000 papers on this subject 2025: 849 of every 10,000 papers on this subject ▲ +57% share 2022→2025 share of research on this subject Works propose frameworks for cohesive digital interventions across public health and clinical settings.
Digital health · Health informatics · Health care · Public health
“IDEAS (Integrate, Design, Assess, and Share): A Framework and Toolkit of Strategies for the Development of More Effective Digital Interventi”
Opportunities · theme 04
Novel Therapeutic Molecule Exploration
941 papers · 15.7% of this block
2022: 512 of every 10,000 papers on this subject 2023: 528 of every 10,000 papers on this subject 2024: 495 of every 10,000 papers on this subject 2025: 494 of every 10,000 papers on this subject 2022: 512 of every 10,000 papers on this subject 2023: 528 of every 10,000 papers on this subject 2024: 495 of every 10,000 papers on this subject 2025: 494 of every 10,000 papers on this subject ▼ -4% share 2022→2025 share of research on this subject Papers describe new drug candidates and mechanisms uncovered through advanced screening.
Drug discovery · Drug · Pharmacology · In vivo
“Development and Characterization of Selective FAK Inhibitors and PROTACs with <i>In Vivo</i> Activity”
Opportunities · theme 05
Precision Oncology for Breast Cancer
787 papers · 13.1% of this block
2022: 893 of every 10,000 papers on this subject 2023: 1,223 of every 10,000 papers on this subject 2024: 954 of every 10,000 papers on this subject 2025: 909 of every 10,000 papers on this subject 2022: 893 of every 10,000 papers on this subject 2023: 1,223 of every 10,000 papers on this subject 2024: 954 of every 10,000 papers on this subject 2025: 909 of every 10,000 papers on this subject → +2% share 2022→2025 share of research on this subject Research highlights rapid mutational profiling and model selection to guide personalized treatment.
Cancer · Precision medicine · Oncology · Breast cancer
“Rapid targeted mutational analysis of human tumours: a clinical platform to guide personalized cancer medicine”
Opportunities · theme 06
Broad Precision Medicine Applications
680 papers · 11.3% of this block
2022: 1,259 of every 10,000 papers on this subject 2023: 1,117 of every 10,000 papers on this subject 2024: 1,011 of every 10,000 papers on this subject 2025: 1,303 of every 10,000 papers on this subject 2022: 1,259 of every 10,000 papers on this subject 2023: 1,117 of every 10,000 papers on this subject 2024: 1,011 of every 10,000 papers on this subject 2025: 1,303 of every 10,000 papers on this subject ▲ +4% share 2022→2025 share of research on this subject Studies demonstrate phenome‑wide analyses and molecular subtyping to refine disease management.
Precision medicine · Personalized medicine · Disease · Health care
“Phenome-Wide Association Studies as a Tool to Advance Precision Medicine”
Opportunities · theme 07
Wearable and Robotic Monitoring
563 papers · 9.4% of this block
2022: 33 of every 10,000 papers on this subject 2023: 34 of every 10,000 papers on this subject 2024: 36 of every 10,000 papers on this subject 2025: 62 of every 10,000 papers on this subject 2022: 33 of every 10,000 papers on this subject 2023: 34 of every 10,000 papers on this subject 2024: 36 of every 10,000 papers on this subject 2025: 62 of every 10,000 papers on this subject ▲ +89% share 2022→2025 share of research on this subject Innovations focus on remote sensors and surgical robots for continuous patient observation.
Wearable computer · Remote patient monitoring · Surgical robot · Robot
“Development of a remote therapeutic monitoring platform: applications for movement disorders”
Which of these themes are growing fastest Tracks how the share of world research on healthtech themes changes between 2022 and 2025.
Problems
how much more (or less) of the world’s research on this subject each theme took up, 2022→2025
gaining share losing share
Health System Integration Issues ▲+98%
Digital Health Implementation Gaps ▲+57%
Barriers to Telehealth Adoption ▲+55%
Medical Device Safety Concerns ▲+55%
Challenges in Drug Discovery ▲+35%
Limits of Precision Medicine ▲+2%
Pandemic‑Driven Telemedicine Strains ▼-68%
Cautions
how much more (or less) of the world’s research on this subject each theme took up, 2022→2025
gaining share losing share
Governance and Informatics Risks ▲+98%
AI Integration Uncertainties ▲+61%
Digital Mental‑Health Intervention Limits ▲+46%
Pharmacogenomics Validation Limits ▲+35%
Precision Oncology Practical Hurdles ▲+2%
Caution on Remote Chronic Care ▼-8%
COVID‑19 Telehealth Perception Issues ▼-65%
Opportunities
how much more (or less) of the world’s research on this subject each theme took up, 2022→2025
gaining share losing share
Wearable and Robotic Monitoring ▲+89%
Integrated Digital Health Platforms ▲+57%
Computational Drug Design Advances ▲+42%
Broad Precision Medicine Applications ▲+4%
Precision Oncology for Breast Cancer ▲+2%
Novel Therapeutic Molecule Exploration ▼-4%
Expanding Telehealth for Seniors ▼-64%
Who files Healthtech patents in the United States Records 666,693 patent filings from 2016‑2025 by about 8,000 organizations, with top filers including Covidien LP and Medtronic.
666,693 filings 2016–20258,000 assigneespeak 71,776 in 2020
Filing momentum
patents published / year
2016: 63,466 2017: 66,366 2018: 63,578 2019: 70,472 2020: 71,776 2021: 70,413 2022: 65,600 2023: 65,286 2024: 66,126 2025: 63,610 2016 2025
Who files the most
Covidien LP 29,348 Boston Scient Scimed 24,762 Medtronic 22,394 Becton Dickinson 18,249 Procter & Gamble 16,178 Ethicon ENDO Surgery 13,723 Kimberly Clark 12,440 Ethicon 11,761 Prism
Go deeper on Healthtech research and innovation
Research themes, patent activity and the companies commercialising them, in one place.
More landscapes
Keep going
Track Healthtech in the United States beyond this page
Radar finds and filters the companies. Prism watches what is being said about them.
About this data: built from Fliar's company, founder, funding, hiring, jobs, news, research and patent trackers, covering the United States. Counts are of companies we track, not of every company that exists. Updated August 2026.
Contact details
Reach this founder through Fliar Radar
Direct contact details for the people on this page are held in Fliar Radar, behind its own access controls.